top of page
Search
Exploring different composite definitions of responders to biologic treatment for severe asthma (FULL BEAM Response)
The International Severe Asthma Registry (ISAR) ’s new study, “ Exploring definitions and predictors of response to biologics for severe...
Jul 10, 20243 min read
Exploring definitions and predictors of severe asthma clinical remission post-biologic in adults (FULL BEAM Remission)
We are excited to share groundbreaking findings on remission as a therapeutic target in " Exploring definitions and predictors of severe...
Jul 9, 20242 min read
International research collaboration affirms benefits of biologic therapies across broad severe asthma patient populations worldwide, but also highlights unmet treatment needs: Results from LUMINANT
Singapore, [25 June 2024] – A new analysis of data from the International Severe Asthma Registry (ISAR) has revealed a spectrum of...
Jun 25, 20243 min read
Ground-breaking new study from ISAR uncovers the power of asthma tests BEC and FeNO to predict effectiveness of biologic therapies in Severe Asthma
A new real-world research study from ISAR, the International Severe Asthma Registry, reveals the strength of the asthma tests...
May 9, 20242 min read
New ISAR Research Sheds Light on Asthma Exacerbation Rates: Great Variability Found Across Nations
The International Severe Asthma Registry is a global collaborative initiative to gather anonymous, longitudinal, real-life data for...
Apr 25, 20241 min read
New evidence reveals the power of biologics to improve severe asthma outcomes in patients with T2 comorbidities
ISAR ’s new publication "Association between T2-related co-morbidities and effectiveness of biologics in severe asthma” to the highly...
Mar 15, 20241 min read
bottom of page